MedTrace Logo

Ultrasound Guidance vs. Landmark Technique for Catheter Malposition in IJV Catheterization

NCT07701720 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2026-07-14

No results posted yet for this study

Summary

Central venous catheterization (CVC) via the internal jugular vein (IJV) is a fundamental procedure in anesthesia and intensive care for hemodynamic monitoring, fluid resuscitation, and vasoactive drug administration. While modern clinical guidelines strongly advocate for ultrasound (USG) guidance, the traditional anatomical landmark technique remains widely utilized due to equipment availability or clinician habits. Proper positioning of the catheter tip is critical to prevent severe long-term complications; however, comparative data regarding catheter tip malposition between these two routine techniques-especially when confirmed by postprocedural bedside chest X-ray-require further prospective evaluation. Objective:

The primary objective of this prospective observational study is to compare ultrasound-guided versus landmark techniques for internal jugular vein catheterization with respect to catheter tip malposition, as determined by postprocedural bedside chest X-ray. Secondary objectives include the evaluation of the number of needle redirections, first-attempt success rate, total procedure time, and the incidence of mechanical complications (such as accidental arterial puncture or hematoma formation)

Conditions

  • Catheter Malposition
  • Central Venous Catheterization

Interventions

PROCEDURE

Landmark Technique

Internal jugular vein catheterization performed using external anatomical landmarks without real-time ultrasound guidance.

PROCEDURE

Ultrasound-Guided Technique

Internal jugular vein catheterization performed with real-time ultrasound visualization of the vein to guide needle insertion.

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2026-10-15
Completion
2026-10-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07701720 on ClinicalTrials.gov